Larionov AA - Search Results

1

Theory of intercellular communication in the development of endothelial dysfunction.

Inzhutova AI, Larionov AA, Petrova MM, Salmina AB. Inzhutova AI, et al. Among authors: larionov aa. Bull Exp Biol Med. 2012 Jun;153(2):201-5. doi: 10.1007/s10517-012-1676-x. Bull Exp Biol Med. 2012. PMID: 22816083 English, Russian.

2

Role of CD38 in cell-cell interactions under conditions of endothelial dysfunction.

Inzhutova AI, Salmina AB, Petrova MM, Larionov AA. Inzhutova AI, et al. Among authors: larionov aa. Bull Exp Biol Med. 2008 Jun;145(6):703-6. doi: 10.1007/s10517-008-0170-y. Bull Exp Biol Med. 2008. PMID: 19110555

3

[Stabilization of cellular membranes as a target of vascular therapy].

Inzhutova AI, Larionov AA, Petrova MM, Salmina AB. Inzhutova AI, et al. Among authors: larionov aa. Kardiologiia. 2011;51(4):52-5. Kardiologiia. 2011. PMID: 21623721 Russian.

4

[Modulation of membrane blebbing and microparticle sheddimg as a target of cardiovascular prophylaxis].

Inzhutova AI, Larionov AA, Lopatina OL. Inzhutova AI, et al. Among authors: larionov aa. Vestn Ross Akad Med Nauk. 2011;(11):23-8. Vestn Ross Akad Med Nauk. 2011. PMID: 22312904 Russian.

5

Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation.

Morone S, Lo-Buono N, Parrotta R, Giacomino A, Nacci G, Brusco A, Larionov A, Ostano P, Mello-Grand M, Chiorino G, Ortolan E, Funaro A. Morone S, et al. PLoS One. 2012;7(8):e43649. doi: 10.1371/journal.pone.0043649. Epub 2012 Aug 20. PLoS One. 2012. PMID: 22916288 Free PMC article.

6

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.

Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S, Murray E, Larionov A, Petrakova K, Muller P, Dixon MJ, Hupp TR, Vojtesek B. Hrstka R, et al. Oncogene. 2010 Aug 26;29(34):4838-47. doi: 10.1038/onc.2010.228. Epub 2010 Jun 7. Oncogene. 2010. PMID: 20531310

7

[Dexamethasone and dibutyryl-cyclic AMP stimulates conversion of androstenedione in human blood lymphocytes].

Bershteĭn LM, Poroshina TE, Larionov AA, Zimarina TS, Kriukova OG. Bershteĭn LM, et al. Among authors: larionov aa. Dokl Akad Nauk. 1997 Jan;352(2):276-7. Dokl Akad Nauk. 1997. PMID: 9102103 Russian. No abstract available.

8

[Androstenedione conversion in human peripheral blood lymphocytes].

Bershteĭn LM, Larionov AA, Kriukova OG. Bershteĭn LM, et al. Among authors: larionov aa. Biull Eksp Biol Med. 1994 May;117(5):517-9. Biull Eksp Biol Med. 1994. PMID: 9296707 Russian. No abstract available.

9

[Conversion of androstenedione in the lymphocytes infiltrating the breast tumor tissue].

Bershteĭn LM, Poroshina TE, Zimarina TS, Larionov AA, Uporov AV. Bershteĭn LM, et al. Among authors: larionov aa. Biull Eksp Biol Med. 1997 Oct;124(10):440-3. Biull Eksp Biol Med. 1997. PMID: 9410179 Russian. No abstract available.

10

[Metabolism of the androgenic precursor androstenedione and effects of aromatase inhibitors in cultured blood lymphocytes].

Bershteĭn LM, Poroshina TE, Larionov AA, Zimarina TS. Bershteĭn LM, et al. Among authors: larionov aa. Ross Fiziol Zh Im I M Sechenova. 1998 Nov;84(11):1242-6. Ross Fiziol Zh Im I M Sechenova. 1998. PMID: 10204168 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters